首页 | 本学科首页   官方微博 | 高级检索  
     

药物标识在白血病化疗患者中的作用效果分析
引用本文:习敏,陈兆军. 药物标识在白血病化疗患者中的作用效果分析[J]. 中华全科医学, 2019, 17(7): 1241-1244. DOI: 10.16766/j.cnki.issn.1674-4152.000911
作者姓名:习敏  陈兆军
作者单位:1. 杭州市丁桥医院肿瘤科, 浙江 杭州 310000;
基金项目:浙江省医药卫生科技项目(2014ZDA018)
摘    要:目的探讨药物标识化管理在白血病患者化疗中的应用。方法选择2016年6月-2017年6月在杭州市丁桥医院血液科工作的41名护理人员作为研究对象,其中2016年6月-2016年12月的18名护理人员作为对照组,2017年1月-2017年6月的23名护理人员作为观察组,对照组未实行药物标识化管理,观察组实行药物标识化管理,比较2组护理人员工作效率、不良反应发生情况以及患者满意度。结果观察组取药差错率为3.55%,药物配置时间为(9.26±2.17)min,对照组取药差错率为19.72%,药物配置时间为(18.95±3.56)s,观察组取药差错率及药物配置时间均明显低于对照组(均P<0.05);观察组发生静脉炎、口腔溃疡、恶心、呕吐不良反应3例,不良反应发生率为5.26%,对照组发生静脉炎、口腔溃疡、恶心、呕吐不良反应10例,不良反应发生率为24.39%,观察组不良反应发生率明显低于对照组(P<0.05);观察组满意度为92.98%,对照组满意度为73.17%,观察组满意度明显高于对照组(P<0.05)。结论药物标识化管理能够明显提高护理人员的工作效率,提升患者满意度,降低不良反应发生率,值得临床推广。

关 键 词:药物标识化管理  白血病  化疗  高危药品
收稿时间:2018-10-20

Application of drug identification in nursing management of leukemia patients undergoing chemotherapy
XI Min,CHEN Zhao-jun. Application of drug identification in nursing management of leukemia patients undergoing chemotherapy[J]. Applied Journal Of General Practice, 2019, 17(7): 1241-1244. DOI: 10.16766/j.cnki.issn.1674-4152.000911
Authors:XI Min  CHEN Zhao-jun
Affiliation:Department of Oncology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou, Zhejiang 310000, China
Abstract:Objective To explore the application of drug identification in the management of leukemia patients undergoing chemotherapy. Methods A total of 41 nursing staff working in the hematology department of Hangzhou Dingqiao hospital from June 2016 to June 2017 were selected as research objects, including 18 nursing staff from June 2016 to December 2016 as the control group and 23 nursing staff from January 2017 to June 2017 as the observation group. In the control group, drug identification was not implemented, while in the observation group drug identification was managed. The work efficiency of nurses, incidence of adverse reactions and patient satisfaction were compared between the two groups. Results The rate of error event for medicine was 3.55% and the drug configuration time (9.26±2.17) min in the observation group, 19.72% and (18.95±3.56) s in the control group, respectively. The rate of error event for medicine and drug configuration time in the observation group was significantly lower than those in the control group (P<0.05); Three cases in the observation group were with adverse reactions (phlebitis, oral ulcer, nausea and vomiting) with an incidence of 5.26%; 10 cases were with the adverse reactions in the control group, with an incidence of 24.39%; the incidence of adverse reactions in the observation group was significantly lower than that in the control group (P<0.05); The patients satisfaction of the observation group was 92.98%, and that of the control group was 73.17%, the satisfaction of observation group was significantly higher than that of control group (P<0.05). Conclusion Drug identification can significantly improve the working efficiency of nursing staff, improve patient satisfaction and reduce the incidence of adverse reactions, and it is worthy of clinical promotion. 
Keywords:Drug identification  Leukemia  Chemotherapy  High-risk drug
本文献已被 维普 等数据库收录!
点击此处可从《中华全科医学》浏览原始摘要信息
点击此处可从《中华全科医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号